Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients

被引：0
|
作者：
Alfonso De Stefano
Chiara Carlomagno
Stefano Pepe
Roberto Bianco
Sabino De Placido
机构：
[1] Università degli Studi di Napoli Federico II,Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Bevacizumab; Arterial hypertension; Metastatic colorectal cancer; Predictive marker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1207 / 1213
页数：6
相关论文
共 50 条
  • [1] Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients
    De Stefano, Alfonso
    Carlomagno, Chiara
    Pepe, Stefano
    Bianco, Roberto
    De Placido, Sabino
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (05) : 1207 - 1213
  • [2] Association between bevacizumab-related hypertension and response to treatment in metastatic colorectal cancer patients.
    Dionisio de Sousa, Isabel Jose
    Casalta-Lopes, Joao
    Rodrigues, Joana
    Pais, Ana
    Bonito, Nuno
    Jacinto, Paula Sousa
    Marques, Mariela
    Ribeiro, Joao
    Gervasio, Maria Helena
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Clinical risk factors of bevacizumab-related hypertension in patients with metastatic colorectal cancer: a retrospective study
    Zheng, Zhuoling
    Zhao, Yihong
    Xie, Jingwen
    Gao, Min
    Wang, Yiting
    Li, Xiaoyan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [4] ASSOCIATION BETWEEN BEVACIZUMAB-RELATED HYPERTENSION AND VEGF GENE POLYMORPHISMS IN JAPANESE COLORECTAL CANCER PATIENTS
    Morita, S.
    Inada, M.
    Shibata, T.
    Oguri, T.
    Shimokata, T.
    Sugishita, M.
    Mitsuma, A.
    Uehara, K.
    Nakayama, G.
    Ando, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 131 - 131
  • [5] The Effect of Bevacizumab-Related Hypertension on the Prognosis of Patients with Colorectal Cancer and Non-Small Cell Lung Cancer
    Pan, Juhua
    Zheng, Liangda
    Liu, Binghui
    You, Shuqing
    Zheng, Weizhi
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 21 - 24
  • [6] Association between bevacizumab-related hypertension and vascular endothelial growth factor (VEGF) gene polymorphisms in Japanese patients with metastatic colorectal cancer
    Sachi Morita
    Keisuke Uehara
    Goro Nakayama
    Takashi Shibata
    Tomoyo Oguri
    Megumi Inada-Inoue
    Tomoya Shimokata
    Mihoko Sugishita
    Ayako Mitsuma
    Yuichi Ando
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 405 - 411
  • [7] Association between bevacizumab-related hypertension and vascular endothelial growth factor (VEGF) gene polymorphisms in Japanese patients with metastatic colorectal cancer
    Morita, Sachi
    Uehara, Keisuke
    Nakayama, Goro
    Shibata, Takashi
    Oguri, Tomoyo
    Inada-Inoue, Megumi
    Shimokata, Tomoya
    Sugishita, Mihoko
    Mitsuma, Ayako
    Ando, Yuichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (02) : 405 - 411
  • [8] Incidence and management of bevacizumab-related toxicities in colorectal cancer
    Saif, M. Wasif
    Mehra, Ranee
    EXPERT OPINION ON DRUG SAFETY, 2006, 5 (04) : 553 - 566
  • [9] Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients
    Takahashi, Toshiaki
    Shigeyasu, Kunitoshi
    Kondo, Yoshitaka
    Takeda, Sho
    Umeda, Hibiki
    Moriwake, Kazuya
    Kayano, Masashi
    Sakurai, Yuya
    Nakamura, Shunsuke
    Takahashi, Masafumi
    Nitta, Kaori
    Yoshida, Kazuhiro
    Matsumi, Yuki
    Michiue, Hiroyuki
    Yamamoto, Hideki
    Kishimoto, Hiroyuki
    Teraishi, Fuminori
    Shoji, Ryohei
    Kanaya, Nobuhiko
    Kashima, Hajime
    Kakiuchi, Yoshihiko
    Kuroda, Shinji
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    BMC CANCER, 2025, 25 (01)
  • [10] BEVACIZUMAB-INDUCED HYPERTENSION IS A PREDICTIVE MARKER OF RESPONSE AND PROGRESSION FREE SURVIVAL IN PATIENTS TREATED FOR METASTATIC COLORECTAL CANCER
    De Stefano, Alfonso
    Carlomagno, Chiara
    Cannella, Lucia
    Crispo, Anna
    Pepe, Stefano
    Alfieri, Salvatore
    Colantuoni, Maria
    Cella, Chiara
    Raimondo, Lucia
    De Placido, Sabino
    ANNALS OF ONCOLOGY, 2009, 20
12345